Rainer M Erdtmann has bought stock on 5 days since Sep 2018
Insider at Biomea Fusion, Inc., and 1 other company
SEC CIK 0001455767 · Filings on SEC.gov ↗
Rainer M Erdtmann's record
3 months after each buy, from the first price a copier could get.
5 buys since 2018 with 3 months of prices.
Companies
Every filing
7 filings since Sep 2018, newest first
Biomea Fusion, Inc.
Insider
Biomea Fusion, Inc.
Insider
Biomea Fusion, Inc.
President, COO and 10% owner
Biomea Fusion, Inc.
President, COO and 10% owner
Biomea Fusion, Inc.
President, COO and 10% owner
Polarityte, Inc.
Director
Polarityte, Inc.
Director
About Rainer M Erdtmann
Rainer M. Erdtmann is a person and a director and officer of Biomea Fusion, Inc. (NASDAQ: BMEA), a clinical-stage biotechnology company focused on therapies for diabetes, obesity, and other metabolic diseases.( Recent insider filings show that he received a grant of 452,512 stock options exercisable at $1.49 per share, with vesting scheduled in quarterly installments through 2030 and expiration in March 2036, reflecting compensation tied to continued service.(
Publicly available insider-trading and ownership data also identify him as Ramses/Rainer Erdtmann on Biomea Fusion’s board of directors and a co-founder, with substantial beneficial ownership reported in 2025.( Available sources emphasize his board role and insider activity, but they do not provide enough verified biographical detail in the search results to reliably confirm his full career history or education.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.